Skip to content
Disclosery

Nan Fung Group Holdings Ltd

Follow

13F filer, CIK 1782539, KAI TAK, Hong Kong

Nan Fung Group Holdings Ltd reported $121,264,536 across 24 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-14. Its ten largest share positions make up 83.4% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001012975-26-000423

Period
2026-03-31
Reported value
$121M
Holdings
24
Top 10 weight
83.4%
New
2
Sold out
5

Largest buys vs the previous quarter

SecurityShares changeApprox. value
LBRXadded+330,657$8.15M
CELCnew+28,300$3.23M
INSMnew+6,580$1.08M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
OCSreduced-163,957-$4.36M
MDGLreduced-6,200-$3.25M
LABexited-1,883,179-$2.41M
REPLexited-63,719-$619K
INCYreduced-5,280-$497K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001012975-26-000423, largest first. % of portfolio is the value over $121,264,536, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,441,032 shares; 2026Q1: 1,441,032 shares 1,441,032$33.1M27.32%0Timeline
MPLTMAPLIGHT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 971,253 shares; 2026Q1: 971,253 shares 971,253$19.7M16.28%0Timeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 300,000 shares; 2026Q1: 630,657 shares 630,657$15.6M12.82%+330,657Timeline
OCSOCULIS HOLDING AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 436,378 shares; 2024Q4: 436,378 shares; 2025Q1: 514,702 shares; 2025Q2: 514,702 shares; 2025Q3: 514,702 shares; 2025Q4: 514,702 shares; 2026Q1: 350,745 shares 350,745$9.33M7.69%-163,957Timeline
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 74,022 shares; 2024Q4: 67,022 shares; 2025Q1: 59,022 shares; 2025Q2: 59,022 shares; 2025Q3: 59,022 shares; 2025Q4: 59,022 shares; 2026Q1: 53,742 shares 53,742$5.06M4.17%-5,280Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 23,022 shares; 2024Q4: 19,997 shares; 2025Q1: 15,722 shares; 2025Q2: 15,722 shares; 2025Q3: 15,722 shares; 2025Q4: 15,722 shares; 2026Q1: 15,722 shares 15,722$4.67M3.85%0Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 49,120 shares; 2024Q4: 49,120 shares; 2025Q1: 49,120 shares; 2025Q2: 49,120 shares; 2025Q3: 49,120 shares; 2025Q4: 49,120 shares; 2026Q1: 49,120 shares 49,120$4.27M3.52%0Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 28,300 shares 28,300$3.23M2.66%newTimeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 13,600 shares; 2024Q4: 13,600 shares; 2025Q1: 13,600 shares; 2025Q2: 13,600 shares; 2025Q3: 13,600 shares; 2025Q4: 13,600 shares; 2026Q1: 13,600 shares 13,600$3.11M2.57%0Timeline
PCORPROCORE TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 53,299 shares; 2026Q1: 53,299 shares 53,299$3.04M2.51%0Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 9,762 shares; 2024Q4: 11,122 shares; 2025Q1: 11,872 shares; 2025Q2: 11,872 shares; 2025Q3: 11,872 shares; 2025Q4: 11,872 shares; 2026Q1: 5,672 shares 5,672$2.97M2.45%-6,200Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 10,875 shares; 2024Q4: 30,875 shares; 2025Q1: 30,875 shares; 2025Q2: 30,875 shares; 2025Q3: 30,875 shares; 2025Q4: 30,875 shares; 2026Q1: 30,875 shares 30,875$2.57M2.12%0Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 102,984 shares; 2024Q4: 102,984 shares; 2025Q1: 102,984 shares; 2025Q2: 102,984 shares; 2025Q3: 102,984 shares; 2025Q4: 102,984 shares; 2026Q1: 102,984 shares 102,984$2.29M1.89%0Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 460,000 shares; 2026Q1: 460,000 shares 460,000$2.21M1.82%0Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 430 shares; 2024Q4: 430 shares; 2025Q1: 2,800 shares; 2025Q2: 2,800 shares; 2025Q3: 2,800 shares; 2025Q4: 2,800 shares; 2026Q1: 2,800 shares 2,800$2.04M1.69%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 7,300 shares; 2024Q4: 19,253 shares; 2025Q1: 19,253 shares; 2025Q2: 19,253 shares; 2025Q3: 19,253 shares; 2025Q4: 19,253 shares; 2026Q1: 19,253 shares 19,253$1.87M1.54%0Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 664,610 shares; 2025Q1: 664,610 shares; 2025Q2: 664,610 shares; 2025Q3: 595,287 shares; 2025Q4: 595,287 shares; 2026Q1: 595,287 shares 595,287$1.83M1.51%0Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,580 shares 6,580$1.08M0.89%newTimeline
ETHAISHARES ETHEREUM TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,549 shares; 2025Q4: 50,549 shares; 2026Q1: 50,549 shares 50,549$800K0.66%0Timeline
HRMYHARMONY BIOSCIENCES HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 368,665 shares; 2024Q4: 368,665 shares; 2025Q1: 368,665 shares; 2025Q2: 368,665 shares; 2025Q3: 27,049 shares; 2025Q4: 27,049 shares; 2026Q1: 27,049 shares 27,049$758K0.62%0Timeline
TRDAENTRADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 49,082 shares; 2024Q4: 49,082 shares; 2025Q1: 49,082 shares; 2025Q2: 49,082 shares; 2025Q3: 49,082 shares; 2025Q4: 49,082 shares; 2026Q1: 49,082 shares 49,082$619K0.51%0Timeline
IBITISHARES BITCOIN TRUST ETFQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 15,968 shares; 2025Q4: 15,968 shares; 2026Q1: 15,968 shares 15,968$613K0.51%0Timeline
RANIRANI THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 493,584 shares; 2024Q4: 493,584 shares; 2025Q1: 493,584 shares; 2025Q2: 493,584 shares; 2025Q3: 493,584 shares; 2025Q4: 493,584 shares; 2026Q1: 493,584 shares 493,584$363K0.3%0Timeline
BOLTBOLT BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 58,347 shares; 2025Q3: 58,347 shares; 2025Q4: 58,347 shares; 2026Q1: 29,250 shares 29,250$118K0.1%-29,097Timeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
LABSTANDARD BIOTOOLS INC1,883,179$2.41Mshares
REPLREPLIMUNE GROUP INC63,719$619Kshares
BCYCBICYCLE THERAPEUTICS PLC68,943$488Kshares
RKLBROCKET LAB CORP3,824$267Kshares
BSLKBOLT PROJS HLDGS INC COM NEW40,597$32.4Kshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001012975-26-000423 base2026-05-14acceptance time not in the bulk data set